Klein Lloyd W, Tamis-Holland Jacqueline, Kirtane Ajay J, Anderson H Vernon, Cigarroa Joaquin, Duffy Peter L, Blankenship James, Valentine C Michael, Welt Frederick Gp
Cardiology Section, University of California, San Francisco, California, USA.
Department of Cardiovascular Diseases, Mount Sinai St. Luke's Hospital, New York, New York, USA.
Catheter Cardiovasc Interv. 2021 Dec 1;98(7):1349-1357. doi: 10.1002/ccd.29784. Epub 2021 Jun 3.
The purpose of this position statement is to suggest ways in which future appropriate use criteria (AUC) for coronary revascularization might be restructured to: (1) incorporate improvement in quality of life and angina relief as primary goals of therapy, (2) integrate the findings of recent trials into quality appraisal, (3) employ the combined information of the coronary angiogram and invasive physiologic measurements together with the results of stress test imaging to assess risk, and (4) recognize the essential role that patient preference plays in making individualized therapeutic decisions. The AUC is a valuable tool within the quality assurance process; it is vital that interventionists ensure that percutaneous coronary intervention case selection is both evidence-based and patient oriented. Appropriate patient selection is an important quality indicator and adherence to evidence-based practice should be one metric in a portfolio of process and outcome indicators that measure quality.
本立场声明的目的是提出一些方法,以便未来对冠状动脉血运重建的适当使用标准(AUC)进行调整,从而:(1)将生活质量改善和心绞痛缓解纳入治疗的主要目标;(2)将近期试验结果纳入质量评估;(3)综合冠状动脉造影和有创生理测量的信息以及负荷试验成像结果来评估风险;(4)认识到患者偏好在做出个体化治疗决策中所起的关键作用。AUC是质量保证过程中的一项宝贵工具;介入医生务必确保经皮冠状动脉介入治疗的病例选择既基于证据又以患者为导向。恰当的患者选择是一项重要的质量指标,遵循循证实践应成为衡量质量的一系列过程和结果指标中的一项标准。